StemRIM (4599)

Currency in JPY
255.0
-4.0(-1.54%)
Closed·
4599 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
253.0259.0
52 wk Range
246.0370.0
Key Statistics
Bid/Ask
254.00 / 255.00
Prev. Close
259
Open
258
Day's Range
253-259
52 wk Range
246-370
Volume
250.6K
Average Volume (3m)
129.31K
1-Year Change
-11.46%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4599 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
700.0
Upside
+174.51%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

StemRIM News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

StemRIM Company Profile

StemRIM, a biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally. The company offers TRIM2, a peptide drug, which is in Phase II clinical trials for the treatment of epidermolysis bullosa, cerebral infarction, myocardial infarction/cardiomyopathy, liver cirrhosis, and knee osteoarthritis. It also provides pre-clinical stage products, including TRIM3 and TRIM4 for the treatment of various tissue damage diseases; and TRIM5, a molecule for tissue repair, as well as SR-GT1, a stem cell gene therapy. The company was incorporated in 2006 and is headquartered in Ibaraki, Japan.

Employees
45
Market
Japan

Compare 4599 to Peers and Sector

Metrics to compare
4599
Peers
Sector
Relationship
P/E Ratio
−8.4x−4.0x−0.6x
PEG Ratio
−0.75−0.080.00
Price/Book
2.3x4.1x2.6x
Price / LTM Sales
-24.2x3.2x
Upside (Analyst Target)
174.5%28.2%42.3%
Fair Value Upside
Unlock9.5%5.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 700.0
(+174.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 10, 2025
EPS / Forecast
-8.49 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4599 Income Statement

FAQ

What Is the StemRIM (4599) Stock Price Today?

The StemRIM stock price today is 255.0

What Stock Exchange Does StemRIM Trade On?

StemRIM is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for StemRIM?

The stock symbol for StemRIM is "4599."

What Is the StemRIM Market Cap?

As of today, StemRIM market cap is 15.98B.

What Is StemRIM's Earnings Per Share (TTM)?

The StemRIM EPS (TTM) is -30.56.

When Is the Next StemRIM Earnings Date?

StemRIM will release its next earnings report on Mar 17, 2026.

From a Technical Analysis Perspective, Is 4599 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has StemRIM Stock Split?

StemRIM has split 0 times.

How Many Employees Does StemRIM Have?

StemRIM has 45 employees.

What is the current trading status of StemRIM (4599)?

As of Dec 27, 2025, StemRIM (4599) is trading at a price of 255.0, with a previous close of 259.0. The stock has fluctuated within a day range of 253.0 to 259.0, while its 52-week range spans from 246.0 to 370.0.

What Is StemRIM (4599) Price Target According to Analysts?

The average 12-month price target for StemRIM is JPY700, with a high estimate of JPY700 and a low estimate of JPY700. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +174.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.